Comparison of lovastatin and hyaluronic acid/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats

International Journal of Surgery

Volumn 12, Issue 2, 2014, Pages 120-124

  Arslan, Ergin ^a   Talih, Tutkun ^b   Oz, Bahadir ^c   Halaclar, Bülent ^d   Caglayan, Kasim ^a   Sipahi, Mesut ^a  

^a BOZOK UNIVERSITY   (Turkey)

^b Kayseri Training and Education Hospital of Medicine   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d Aksaray State Hospital   (Turkey)

Author keywords

Adhesion severity; Lovastatin; Peritoneal adhesion; Seprafilm

Indexed keywords

CARBOXYMETHYLCELLULOSE; HYALURONIC ACID; MALONALDEHYDE; MEVINOLIN; NITRIC OXIDE; TISSUE PLASMINOGEN ACTIVATOR;

ADHESION BARRIER FILM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; EXPERIMENTAL STUDY; FEMALE; HISTOPATHOLOGY; LAPAROTOMY; MICROSCOPY; NONHUMAN; PERITONEUM ADHESION; POSTOPERATIVE COMPLICATION; RAT; RAT MODEL; RELIABILITY;

ADHESION SEVERITY; LOVASTATIN; PERITONEAL ADHESION; SEPRAFILM;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HYALURONIC ACID; LOVASTATIN; PERITONEAL DISEASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; TISSUE ADHESIONS;

EID: 84893950303     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2013.11.010     Document Type: Article

References (31)

1. Li T.C., Cooke I.D. The value of an absorbable adhesion barrier. Interceed in the prevention of adhesion reformation following microsurgical adhesiolysis. Br J Obstet Gyneacol 1994, 101:335-339.
2. Liakakos T., Thomakos N., Fine P.M., Dervenis C., Young R.L. Peritoneal adhesions; etiology, pathophysiology, and clinical significance. Dig Surg 2001, 18:260-273.
3. Tito W.A., Sarr M.G. Intestinal obstructions. Schakelfords surgery of the alimentary tract 1996, vol. 5:375-416. WB Saunders, Philadelphia.
4. Holtz G. Prevention and management of peritoneal adhesions. Fertil Steril 1984, 41:497-507.
5. Coleman M.G., McLain A.D., Moran B.J. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum 2000, 43:1297-1299.
6. Van Der Krabben A.A., Dijkstra F.R., Nieuwenhuijzen M., Reijnen M.M., Schaapveld M., van Goor H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000, 87:467-471.
7. Holmdahl L., Ericsson E., Al-Jabreen M., Risberg B. Fibrinolysis in human peritoneum during operation. Surgery 1996, 119:701-705.
8. Rodgers K.E., Di Zeregga G.S. Function of peritoneal exudate cells after abdominal surgery. JInvest Surg 1993, 6:9-23.
9. Holmdahl L., Ericsson E., Ericsson B.I., Risberg B. Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery 1998, 13:539-544.
10. Diamond M.P. Reduction of adhesions after uterine mymectomy by Seprafilm membrane (Half): a blinded, prospective, multicenter clinical study. Fertil Steril 1996, 66:904-910.
11. De Cherney A.H., di Zerega G.S. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention bariers. Surg Clin North Am 1997, 77:671-688.
12. Felton R.C., Tuggle D.W., Milewichz Al, et al. High mortality with an intraperitoneal antiadhesive in the rat. Curr Surg 1990, 6:444-446.
13. Haney A.F., Doty E.D. Murine peritoneal injury and de novo adhesion formation caused by oxidized-regenerated cellulose(Interceed[TC7]) but not expanded polytetrafluoroethylene. Fertil Steril 1992, 57:20-28.
14. Tang C.-L., Seow-Choen F., Fook-Chong S., Eu K.-W. Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal exision: a prospective, randomized trial. Dis Colon Rectum 2003, 46:1200-1207.
15. Aarons C.B., Cohen P.A., Gower A. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007, 245:176-184.
16. Majuzi M.K., Kalambahati K., Powar B. Prevention of adhesions with polyvinylpyrrolidone. Arch Surg 1964, 89:1011-1015.
17. Luijendijk R.W., De Lange D.C.D., Wauters C.C.A.P., et al. Foreign material in postoperative adhesions. Ann Surg 1996, 223:242-248.
18. Kamal A.A., Gomaa A., el Khafif M., Hammad A.S. Plasma lipid peroxides among workers exposed to silica or asbestos dusts. Environ. Res. 1989, 49(2):173-180.
19. Grisham M.B., Johnson G.G., Gautreaux M.D., Berg R.D. Measurement of nitrate and nitrite in extracellular fluids: a window to systemic nitric oxide metabolism. Methods: a companion to methods enzymology 1995, vol. 7:84-90.
20. Hershlag A., Otternes I., Blivers M., et al. The effect of interleukin-1 adhesion formation in the rat. Am J Obstet Gynecol 1991, 165:771-774.
21. Oncel M., Remzi F.H., Senagore A.J., Connor J.T., Fazio V.W. Comparison of a novel liquid (Adcon-P) and a sodium hyalurinate and carboxymethylcellulose membrane (Seprafilm) in postsurgical adhesion formation in a murine model. Dis Colon Rectum 2003, 46187-46191.
22. Becker J.M., Dayton M.T., Fazio V.W., et al. Prevention of postoperative abdominal adhesions by a sodium hyalurinate based bioresorbable membrane: a prospective randomized, double-blind multicenter study. JAm Coll Surg 1996, 183:297-306.
23. Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006, 6:358-370.
24. Spitzer A.L., Harris H.W. Statins attenuate sepsis. Surgery 2006, 139:283-287.
25. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071-1080.
26. LaRosa J.C., Grundy S.M., Waters D.D., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. NEngl J Med 2005, 352:1425-1435.
27. Eberlein M., Heusinger-Ribeiro J., Goppelt-Struebe M. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br J Pharmacol 2001, 133:1172-1180.
28. Patel R., Nagueh S.F., Tsybouleva N., et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001, 104:317-324.
29. Watts K.L., Sampson E.M., Schultz G.S., Spiteri M.A. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. Am J Respir Cell Mol Biol 2005, 32:290-300.
30. Burke J.P., Watson R.W.G., Murphy M., Docherty N.G., Coffey J.C., O'Connell P.R. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor β1-mediated activation of intestinal fibroblasts. Br J Surg 2009, 96:541-551.
31. Lalountas M.A., Balllas K.D., Skouras C., et al. Preventing intraperitoneal adhesions with atorvastatin and sodium hyaluronate/carboxymethylcellulose: a comparative study in rats. Am J Surg 2010, 200:118-123.